Close

Seaweeds – A Part of Everyday Life

An informative video on the roles, applications and values of marine macroalgae, or seaweeds, in marine ecosystems, our economy and society. Seaweeds are the largest crop cultivated at sea (46%), and are in many diverse applications we used every day, often without realizing it. For more information on this project, contact Dr. Thierry Chopin, UNB marine biology professor and scientific director of the Canadian Integrated Multi-Trophic Aquaculture Network (CIMTAN) at tchopin@unb.ca.

2013 BIO International Convention in Chicago

Lily Rin-Laures, M.D., previous president of the Chicago chapter of Women in Bio, discusses the biotech industry in Illinois and the upcoming 2013 BIO International Convention.

BIO's Deputy General Counsel of IP discusses upcoming BIO International Convention

Hans Sauer tells us why the 2012 BIO International Convention is a can't-miss event if you are interested in issues concerning intellectual property, tech transfer and related topics.

Integrating TSCA into Commercialization Plans for Renewable Chemicals

Renewable chemicals are emerging at a fast pace, paving the way for new, innovative, and sustainable bio-based products. Technologies continue to proliferate that will further enhance the commercial potential of enzymes, new microbes, biomass, and other bio-engineered materials. In a webinar, BIO and the experts from the law firm of Bergeson and Campbell PC explore TSCA and its application to renewable chemicals.

Brent Erickson Discusses Advanced Biofuels and the BIO International Convention’s Leadership Summit

Brent Erickson, executive vice president for BIO's Industrial & Environmental Section, talks about the key advanced biofuel technologies that will be featured and the policies that support their emergence.

Phyllis Dillinger, Women in Bio

Phyllis discusses the importance of making connections in the industry to propel women into leadership roles, and plans for the upcoming BIO International Convention in Boston, Mass. On June 18-21.

Ronald Stotish, President & CEO of AquaBounty, on Animal Biotech and the 2012 BIO International Convention

Hear from Ron Stotish, President & CEO, AquaBounty, as he discusses the challenges facing the animal biotech field and the state of the industry in MA ahead of the 2012 BIO International Convention.

BIO and BVGH on Global Health

BIO's President and CEO Jim Greenwood talks to BIO Ventures for Global Health (BVGH) CEO Don Joseph about global health and BVGH's new report on global health.

Andrew Emmett on PDUFA and the 2012 BIO International Convention

Andrew Emmett, Managing Director, Science & Regulatory Affairs, speaks about the important regulatory issues facing the industry, specifically PDUFA reauthorization, the FDA and regulation. Also, hear his programming highlights from the Achieving Regulatory Approval and Compliance Track at the upcoming 2012 BIO International Convention.

Therapeutic Discovery Project Defending America's Competitiveness in Biotechnology

Capital formation challenges in the industry have forced many biotech companies to halt projects, lay off staff or shutdown all together. Our analysis shows that the industry is approximately one-quarter smaller than it was in 2008.